Profilo
Jan K.
Öhrström is currently Chairman at Blaze Bioscience, Inc. since 2015, Chairman at ONWARD Medical SA, Chairman at VarmX BV since 2023, Director at Polyganics BV, and President at Sitkabv.
Former positions include Chief Executive Officer at Profibrix BV from 2011 to 2014, Executive Chairman at Biom'Up SA in 2019, Chairman at GTX medical BV from 2016 to 2024, Director at Avigen, Inc., Director-Strategic Marketing at Novo Nordisk A from 1990 to 1999, Medical Director at Novo Nordisk Pharmaceutical Industries, Inc. from 1990 to 1999, and Senior Vice President-Business Development at ZymoGenetics, Inc. from 2000 to 2007.
Education includes a doctorate from the University of Copenhagen conferred in 1984.
Posizioni attive di Jan Öhrström
| Società | Posizione | Inizio |
|---|---|---|
Blaze Bioscience, Inc.
Blaze Bioscience, Inc. Medical/Nursing ServicesHealth Services Develops products for cancer patients | Presidente | 01/04/2015 |
Polyganics BV
Polyganics BV Medical SpecialtiesHealth Technology Develops and produces bioresorbable polymer based products | Direttore/Membro del Consiglio | - |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Presidente | - |
Sitkabv | Presidente | - |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Presidente | 01/11/2018 |
Precedenti posizioni note di Jan Öhrström
| Società | Posizione | Fine |
|---|---|---|
| ONWARD MEDICAL N.V. | Presidente | 31/12/2024 |
| BIOM'UP | Presidente | 31/12/2019 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Corporate Officer/Principal | 01/07/2007 |
| NOVO NORDISK A/S | Vendite & Marketing | 01/01/1999 |
| ░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jan Öhrström
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Blaze Bioscience, Inc.
Blaze Bioscience, Inc. Medical/Nursing ServicesHealth Services Develops products for cancer patients | Health Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk Pharmaceutical Industries, Inc.
Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Polyganics BV
Polyganics BV Medical SpecialtiesHealth Technology Develops and produces bioresorbable polymer based products | Health Technology |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Biom'Up SA
Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
GTX medical BV
GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Sitkabv |
















